What is usability testing for medical devices?

Usability testing is a structured process of evaluating medical devices and IVDs to verify their safety, intuitiveness, and user performance in real-life scenarios. According to MDR 2017/745 and IVDR 2017/746, such testing is mandatory when the user’s actions can directly impact the clinical outcome. The process follows IEC 62366-1 and is closely tied to risk management under ISO 14971.

Usability testing includes:

  • formative evaluations – during product development,
  • summative evaluations – final validation of the finished device,
  • comparative testing – especially for updates to legacy devices.

Usability engineering in device design

Usability engineering is a user-centered design process that ensures a device can be used safely and effectively. It must be documented as part of the quality management system compliant with ISO 13485 and included in the technical documentation. The manufacturer must design user-device interaction in a way that minimizes use-related risks.

The process involves:

  • identifying users and their needs,
  • designing the user interface and instructions,
  • analyzing use-related hazards and errors,
  • conducting both formative and summative testing.

User and use environment analysis

Manufacturers must define intended users (e.g. clinicians, technicians, patients) and use environments (e.g. hospital, home, lab). This analysis includes cognitive, physical, and organizational limitations, as well as environmental factors that may affect device use.

Its outcome supports the development of training materials and instructions tailored to user capabilities.

User interface and instructions for use

The user interface includes all physical, digital, and informational elements through which users interact with the device. These elements must be ergonomic, unambiguous, and aligned with device functionality.

The instructions for use (IFU) form part of the technical documentation and must include:

  • functional description,
  • step-by-step usage instructions,
  • warnings and contraindications,
  • diagrams, technical data, service and certification details.

Usability testing and product development

Usability testing is carried out with representative users in simulated or real use conditions. It helps identify:

  • operational difficulties,
  • use-related errors,
  • non-intuitive interface elements.

Results inform design and documentation improvements. Summative testing is required for Class IIb, III, and innovative devices.

Risk assessment in the usability context

Usability-related risks are considered clinical risks. As per ISO 14971, the manufacturer must identify potential use errors caused by:

  • ambiguous signals or alarms,
  • complex operational sequences,
  • unclear or overloaded instructions,
  • mismatch between user expectations and device behavior.

These risks must be mitigated through engineering or instructional controls and monitored via post-market surveillance.

Usability of software as a medical device (SaMD)

For SaMD, usability focuses on:

  • clarity of the graphical interface,
  • accuracy of system messaging,
  • reducing risk of misinterpretation,
  • performance in various hardware environments and under stress conditions.

Software must include a user support system and instructional materials validated with end users.

Stability of active medical devices

Stability refers to the device’s ability to maintain performance over time and under environmental stress. Evaluation includes:

  • resistance to temperature, humidity, vibration, and impact,
  • performance during power loss or fluctuation,
  • durability of mechanical and electronic components.

Stability data must be included in the technical file and reviewed by the Notified Body during conformity assessment.

Upgrading legacy devices under MDD

Legacy devices (previously certified under MDD) must be updated to meet MDR usability requirements. This includes:

  • modernizing user interfaces,
  • revising instructions for use,
  • conducting new summative testing,
  • reclassifying use-related risks after functional changes.

Such upgrades are essential for maintaining market presence after the MDR transitional period (until 2028), as per Article 120.

MDR requirements for usability

Annex I of MDR 2017/745 requires that devices be designed to:

  • minimize use-related errors,
  • ensure intuitive and unambiguous operation,
  • enable correct use by intended users in the intended environment.

The final phase of usability evaluation is summative testing, which must be documented in a usability report. This report is part of the conformity assessment and is required for market approval.

How Pure Clinical can support your usability testing

Pure Clinical provides comprehensive support to medical and IVD device manufacturers in planning and executing usability testing. Our services include:

  • usability engineering plans and user analysis,
  • identification and classification of use errors,
  • formative and summative testing with users,
  • preparation of reports in accordance with IEC 62366-1 and ISO 14971.

We support SaMD, Class IIb/III, IVDs, and legacy devices transitioning to MDR compliance.

FAQ

Do usability tests need to be repeated if only the packaging or graphic design is modified?

Yes – any change affecting perception, interaction, or user behavior (including labels, colors, pictograms, or visual instructions) may require re-evaluation. Notified bodies expect justification showing that no new usability-related risks are introduced, even if the device itself remains technically unchanged.

Can usability studies be conducted remotely using digital simulations or VR?

Yes – remote usability testing using simulated environments, interactive prototypes, or virtual reality is increasingly accepted, especially for SaMD and user interfaces. However, these methods must realistically replicate usage scenarios and be supported by validation of the testing environment.

Can a notified body reject a device based on usability test results?

Yes – if summative usability testing reveals critical use errors that pose clinical risks, the notified body may require design, instruction, or educational material modifications before approval. Lack of effective usability engineering may be considered non-compliance with MDR.